nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ankylosing spondylitis—osteoporosis	0.422	1	CtDrD
Prednisone—Exemestane—Estropipate—osteoporosis	0.101	0.407	CrCrCtD
Prednisone—Exemestane—Conjugated Estrogens—osteoporosis	0.0764	0.309	CrCrCtD
Prednisone—Danazol—Ethinyl Estradiol—osteoporosis	0.041	0.166	CrCrCtD
Prednisone—ALB—Estropipate—osteoporosis	0.0326	0.16	CbGbCtD
Prednisone—SLCO1A2—Conjugated Estrogens—osteoporosis	0.0299	0.146	CbGbCtD
Prednisone—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.0293	0.118	CrCrCtD
Prednisone—SLCO1A2—Estradiol—osteoporosis	0.0262	0.128	CbGbCtD
Prednisone—ALB—Estradiol—osteoporosis	0.0136	0.0663	CbGbCtD
Prednisone—ABCB1—Ethinyl Estradiol—osteoporosis	0.011	0.0538	CbGbCtD
Prednisone—CYP2C19—Cholecalciferol—osteoporosis	0.0109	0.0533	CbGbCtD
Prednisone—CYP3A4—Estropipate—osteoporosis	0.0102	0.05	CbGbCtD
Prednisone—CYP3A4—Calcitriol—osteoporosis	0.0102	0.05	CbGbCtD
Prednisone—CYP2C19—Estradiol—osteoporosis	0.00879	0.043	CbGbCtD
Prednisone—CYP3A4—Ergocalciferol—osteoporosis	0.00818	0.04	CbGbCtD
Prednisone—ABCB1—Conjugated Estrogens—osteoporosis	0.00807	0.0395	CbGbCtD
Prednisone—ABCB1—Estradiol—osteoporosis	0.00709	0.0347	CbGbCtD
Prednisone—CYP3A4—Raloxifene—osteoporosis	0.00682	0.0334	CbGbCtD
Prednisone—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00659	0.0322	CbGbCtD
Prednisone—CYP3A4—Cholecalciferol—osteoporosis	0.00527	0.0258	CbGbCtD
Prednisone—CYP3A4—Conjugated Estrogens—osteoporosis	0.00484	0.0237	CbGbCtD
Prednisone—CYP3A4—Estradiol—osteoporosis	0.00425	0.0208	CbGbCtD
Prednisone—Exemestane—CYP19A1—osteoporosis	0.00032	0.186	CrCbGaD
Prednisone—Testolactone—CYP19A1—osteoporosis	0.000306	0.178	CrCbGaD
Prednisone—Danazol—SHBG—osteoporosis	0.0002	0.117	CrCbGaD
Prednisone—Methyltestosterone—SHBG—osteoporosis	0.000169	0.0985	CrCbGaD
Prednisone—Danazol—CYP19A1—osteoporosis	0.000147	0.0855	CrCbGaD
Prednisone—Danazol—ESR1—osteoporosis	0.000135	0.0787	CrCbGaD
Prednisone—Hydrocortisone—SHBG—osteoporosis	0.000128	0.0742	CrCbGaD
Prednisone—Methyltestosterone—CYP19A1—osteoporosis	0.000124	0.0723	CrCbGaD
Prednisone—Betamethasone—CYP19A1—osteoporosis	0.00012	0.0697	CrCbGaD
Prednisone—Dexamethasone—CYP19A1—osteoporosis	6.97e-05	0.0406	CrCbGaD
Prednisone—Haemoglobin—Estradiol—osteoporosis	6.26e-05	0.000657	CcSEcCtD
Prednisone—Infection—Pamidronate—osteoporosis	6.24e-05	0.000655	CcSEcCtD
Prednisone—Urticaria—Calcitriol—osteoporosis	6.24e-05	0.000655	CcSEcCtD
Prednisone—Haemorrhage—Estradiol—osteoporosis	6.23e-05	0.000654	CcSEcCtD
Prednisone—Abdominal pain—Calcitriol—osteoporosis	6.21e-05	0.000652	CcSEcCtD
Prednisone—Body temperature increased—Calcitriol—osteoporosis	6.21e-05	0.000652	CcSEcCtD
Prednisone—Angioedema—Conjugated Estrogens—osteoporosis	6.19e-05	0.00065	CcSEcCtD
Prednisone—Shock—Pamidronate—osteoporosis	6.18e-05	0.000649	CcSEcCtD
Prednisone—Loss of consciousness—Zoledronate—osteoporosis	6.18e-05	0.000649	CcSEcCtD
Prednisone—Hypersensitivity—Estropipate—osteoporosis	6.16e-05	0.000647	CcSEcCtD
Prednisone—Nervous system disorder—Pamidronate—osteoporosis	6.16e-05	0.000647	CcSEcCtD
Prednisone—Vomiting—Etidronic acid—osteoporosis	6.15e-05	0.000645	CcSEcCtD
Prednisone—Tachycardia—Pamidronate—osteoporosis	6.13e-05	0.000644	CcSEcCtD
Prednisone—Connective tissue disorder—Estradiol—osteoporosis	6.12e-05	0.000642	CcSEcCtD
Prednisone—Rash—Etidronic acid—osteoporosis	6.1e-05	0.00064	CcSEcCtD
Prednisone—Convulsion—Zoledronate—osteoporosis	6.1e-05	0.00064	CcSEcCtD
Prednisone—Dermatitis—Etidronic acid—osteoporosis	6.09e-05	0.000639	CcSEcCtD
Prednisone—Vertigo—Conjugated Estrogens—osteoporosis	6.09e-05	0.000639	CcSEcCtD
Prednisone—Hyperhidrosis—Pamidronate—osteoporosis	6.08e-05	0.000638	CcSEcCtD
Prednisone—Syncope—Conjugated Estrogens—osteoporosis	6.08e-05	0.000637	CcSEcCtD
Prednisone—Hypertension—Zoledronate—osteoporosis	6.07e-05	0.000637	CcSEcCtD
Prednisone—Hypersensitivity—Alendronate—osteoporosis	6.07e-05	0.000637	CcSEcCtD
Prednisone—Headache—Etidronic acid—osteoporosis	6.06e-05	0.000636	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Risedronate—osteoporosis	6.02e-05	0.000632	CcSEcCtD
Prednisone—Asthenia—Estropipate—osteoporosis	6e-05	0.00063	CcSEcCtD
Prednisone—Anorexia—Pamidronate—osteoporosis	5.99e-05	0.000629	CcSEcCtD
Prednisone—Myalgia—Zoledronate—osteoporosis	5.99e-05	0.000629	CcSEcCtD
Prednisone—Arthralgia—Zoledronate—osteoporosis	5.99e-05	0.000629	CcSEcCtD
Prednisone—Insomnia—Risedronate—osteoporosis	5.98e-05	0.000628	CcSEcCtD
Prednisone—Anxiety—Zoledronate—osteoporosis	5.97e-05	0.000626	CcSEcCtD
Prednisone—Loss of consciousness—Conjugated Estrogens—osteoporosis	5.95e-05	0.000625	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	5.95e-05	0.000624	CcSEcCtD
Prednisone—Paraesthesia—Risedronate—osteoporosis	5.94e-05	0.000623	CcSEcCtD
Prednisone—Pruritus—Estropipate—osteoporosis	5.92e-05	0.000621	CcSEcCtD
Prednisone—Discomfort—Zoledronate—osteoporosis	5.92e-05	0.000621	CcSEcCtD
Prednisone—Asthenia—Alendronate—osteoporosis	5.91e-05	0.00062	CcSEcCtD
Prednisone—Hypersensitivity—Ibandronate—osteoporosis	5.91e-05	0.00062	CcSEcCtD
Prednisone—Convulsion—Conjugated Estrogens—osteoporosis	5.87e-05	0.000616	CcSEcCtD
Prednisone—Fatigue—Ethinyl Estradiol—osteoporosis	5.85e-05	0.000614	CcSEcCtD
Prednisone—Pruritus—Alendronate—osteoporosis	5.83e-05	0.000612	CcSEcCtD
Prednisone—Dyspepsia—Risedronate—osteoporosis	5.82e-05	0.000611	CcSEcCtD
Prednisone—Eye disorder—Estradiol—osteoporosis	5.82e-05	0.000611	CcSEcCtD
Prednisone—Constipation—Ethinyl Estradiol—osteoporosis	5.8e-05	0.000609	CcSEcCtD
Prednisone—Hypersensitivity—Calcitriol—osteoporosis	5.79e-05	0.000607	CcSEcCtD
Prednisone—Flushing—Estradiol—osteoporosis	5.78e-05	0.000607	CcSEcCtD
Prednisone—Arthralgia—Conjugated Estrogens—osteoporosis	5.77e-05	0.000605	CcSEcCtD
Prednisone—Myalgia—Conjugated Estrogens—osteoporosis	5.77e-05	0.000605	CcSEcCtD
Prednisone—Asthenia—Ibandronate—osteoporosis	5.76e-05	0.000604	CcSEcCtD
Prednisone—Anxiety—Conjugated Estrogens—osteoporosis	5.75e-05	0.000603	CcSEcCtD
Prednisone—Nausea—Etidronic acid—osteoporosis	5.74e-05	0.000603	CcSEcCtD
Prednisone—Anaphylactic shock—Zoledronate—osteoporosis	5.74e-05	0.000603	CcSEcCtD
Prednisone—Oedema—Zoledronate—osteoporosis	5.74e-05	0.000603	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	5.73e-05	0.000601	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Pamidronate—osteoporosis	5.73e-05	0.000601	CcSEcCtD
Prednisone—Diarrhoea—Estropipate—osteoporosis	5.72e-05	0.000601	CcSEcCtD
Prednisone—Infection—Zoledronate—osteoporosis	5.7e-05	0.000599	CcSEcCtD
Prednisone—Fatigue—Risedronate—osteoporosis	5.7e-05	0.000598	CcSEcCtD
Prednisone—Insomnia—Pamidronate—osteoporosis	5.69e-05	0.000597	CcSEcCtD
Prednisone—Pruritus—Ibandronate—osteoporosis	5.68e-05	0.000596	CcSEcCtD
Prednisone—Constipation—Risedronate—osteoporosis	5.65e-05	0.000593	CcSEcCtD
Prednisone—Angiopathy—Estradiol—osteoporosis	5.65e-05	0.000593	CcSEcCtD
Prednisone—Shock—Zoledronate—osteoporosis	5.65e-05	0.000593	CcSEcCtD
Prednisone—Paraesthesia—Pamidronate—osteoporosis	5.64e-05	0.000592	CcSEcCtD
Prednisone—Diarrhoea—Alendronate—osteoporosis	5.64e-05	0.000592	CcSEcCtD
Prednisone—Asthenia—Calcitriol—osteoporosis	5.64e-05	0.000591	CcSEcCtD
Prednisone—Nervous system disorder—Zoledronate—osteoporosis	5.63e-05	0.000591	CcSEcCtD
Prednisone—Immune system disorder—Estradiol—osteoporosis	5.63e-05	0.00059	CcSEcCtD
Prednisone—Tachycardia—Zoledronate—osteoporosis	5.6e-05	0.000588	CcSEcCtD
Prednisone—Feeling abnormal—Ethinyl Estradiol—osteoporosis	5.59e-05	0.000586	CcSEcCtD
Prednisone—Skin disorder—Zoledronate—osteoporosis	5.58e-05	0.000585	CcSEcCtD
Prednisone—Pruritus—Calcitriol—osteoporosis	5.56e-05	0.000583	CcSEcCtD
Prednisone—Hyperhidrosis—Zoledronate—osteoporosis	5.55e-05	0.000582	CcSEcCtD
Prednisone—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	5.55e-05	0.000582	CcSEcCtD
Prednisone—Diarrhoea—Raloxifene—osteoporosis	5.55e-05	0.000582	CcSEcCtD
Prednisone—Dyspepsia—Pamidronate—osteoporosis	5.53e-05	0.000581	CcSEcCtD
Prednisone—Dizziness—Estropipate—osteoporosis	5.53e-05	0.000581	CcSEcCtD
Prednisone—Anaphylactic shock—Conjugated Estrogens—osteoporosis	5.53e-05	0.00058	CcSEcCtD
Prednisone—Oedema—Conjugated Estrogens—osteoporosis	5.53e-05	0.00058	CcSEcCtD
Prednisone—Alopecia—Estradiol—osteoporosis	5.5e-05	0.000578	CcSEcCtD
Prednisone—Infection—Conjugated Estrogens—osteoporosis	5.49e-05	0.000576	CcSEcCtD
Prednisone—Diarrhoea—Ibandronate—osteoporosis	5.49e-05	0.000576	CcSEcCtD
Prednisone—Anorexia—Zoledronate—osteoporosis	5.47e-05	0.000574	CcSEcCtD
Prednisone—Decreased appetite—Pamidronate—osteoporosis	5.46e-05	0.000573	CcSEcCtD
Prednisone—Mental disorder—Estradiol—osteoporosis	5.46e-05	0.000573	CcSEcCtD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	5.45e-05	0.00188	CbGpPWpGaD
Prednisone—Dizziness—Alendronate—osteoporosis	5.45e-05	0.000572	CcSEcCtD
Prednisone—Shock—Conjugated Estrogens—osteoporosis	5.44e-05	0.000571	CcSEcCtD
Prednisone—Nervous system disorder—Conjugated Estrogens—osteoporosis	5.42e-05	0.000569	CcSEcCtD
Prednisone—Erythema—Estradiol—osteoporosis	5.42e-05	0.000569	CcSEcCtD
Prednisone—Malnutrition—Estradiol—osteoporosis	5.42e-05	0.000569	CcSEcCtD
Prednisone—Fatigue—Pamidronate—osteoporosis	5.42e-05	0.000569	CcSEcCtD
Prednisone—Gastrointestinal pain—Risedronate—osteoporosis	5.41e-05	0.000567	CcSEcCtD
Prednisone—CYP2C19—Biological oxidations—CYP27A1—osteoporosis	5.4e-05	0.00186	CbGpPWpGaD
Prednisone—Tachycardia—Conjugated Estrogens—osteoporosis	5.4e-05	0.000566	CcSEcCtD
Prednisone—Urticaria—Ethinyl Estradiol—osteoporosis	5.39e-05	0.000565	CcSEcCtD
Prednisone—Constipation—Pamidronate—osteoporosis	5.38e-05	0.000564	CcSEcCtD
Prednisone—Diarrhoea—Calcitriol—osteoporosis	5.37e-05	0.000564	CcSEcCtD
Prednisone—Skin disorder—Conjugated Estrogens—osteoporosis	5.37e-05	0.000564	CcSEcCtD
Prednisone—Body temperature increased—Ethinyl Estradiol—osteoporosis	5.36e-05	0.000563	CcSEcCtD
Prednisone—Abdominal pain—Ethinyl Estradiol—osteoporosis	5.36e-05	0.000563	CcSEcCtD
Prednisone—Dizziness—Raloxifene—osteoporosis	5.36e-05	0.000562	CcSEcCtD
Prednisone—Hyperhidrosis—Conjugated Estrogens—osteoporosis	5.34e-05	0.000561	CcSEcCtD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	5.34e-05	0.00184	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP27A1—osteoporosis	5.32e-05	0.00183	CbGpPWpGaD
Prednisone—Vomiting—Estropipate—osteoporosis	5.32e-05	0.000558	CcSEcCtD
Prednisone—Dizziness—Ibandronate—osteoporosis	5.31e-05	0.000557	CcSEcCtD
Prednisone—Rash—Estropipate—osteoporosis	5.28e-05	0.000554	CcSEcCtD
Prednisone—Dermatitis—Estropipate—osteoporosis	5.27e-05	0.000553	CcSEcCtD
Prednisone—Anorexia—Conjugated Estrogens—osteoporosis	5.27e-05	0.000553	CcSEcCtD
Prednisone—Urticaria—Risedronate—osteoporosis	5.25e-05	0.000551	CcSEcCtD
Prednisone—Headache—Estropipate—osteoporosis	5.24e-05	0.00055	CcSEcCtD
Prednisone—Vomiting—Alendronate—osteoporosis	5.24e-05	0.00055	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Zoledronate—osteoporosis	5.23e-05	0.000549	CcSEcCtD
Prednisone—Body temperature increased—Risedronate—osteoporosis	5.23e-05	0.000549	CcSEcCtD
Prednisone—Abdominal pain—Risedronate—osteoporosis	5.23e-05	0.000549	CcSEcCtD
Prednisone—Rash—Alendronate—osteoporosis	5.2e-05	0.000545	CcSEcCtD
Prednisone—Insomnia—Zoledronate—osteoporosis	5.19e-05	0.000545	CcSEcCtD
Prednisone—Dermatitis—Alendronate—osteoporosis	5.19e-05	0.000545	CcSEcCtD
Prednisone—Feeling abnormal—Pamidronate—osteoporosis	5.18e-05	0.000544	CcSEcCtD
Prednisone—Headache—Alendronate—osteoporosis	5.16e-05	0.000542	CcSEcCtD
Prednisone—Paraesthesia—Zoledronate—osteoporosis	5.16e-05	0.000541	CcSEcCtD
Prednisone—Vomiting—Raloxifene—osteoporosis	5.15e-05	0.000541	CcSEcCtD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ANXA2—osteoporosis	5.14e-05	0.00177	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Pamidronate—osteoporosis	5.14e-05	0.000539	CcSEcCtD
Prednisone—Rash—Raloxifene—osteoporosis	5.11e-05	0.000536	CcSEcCtD
Prednisone—ALB—Folate Metabolism—MTHFR—osteoporosis	5.11e-05	0.00176	CbGpPWpGaD
Prednisone—Dermatitis—Raloxifene—osteoporosis	5.11e-05	0.000536	CcSEcCtD
Prednisone—Vomiting—Ibandronate—osteoporosis	5.1e-05	0.000535	CcSEcCtD
Prednisone—Headache—Raloxifene—osteoporosis	5.08e-05	0.000533	CcSEcCtD
Prednisone—Rash—Ibandronate—osteoporosis	5.06e-05	0.000531	CcSEcCtD
Prednisone—Dermatitis—Ibandronate—osteoporosis	5.05e-05	0.00053	CcSEcCtD
Prednisone—Dyspepsia—Zoledronate—osteoporosis	5.05e-05	0.00053	CcSEcCtD
Prednisone—ALB—Hemostasis—WDR1—osteoporosis	5.05e-05	0.00174	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	5.04e-05	0.000529	CcSEcCtD
Prednisone—Ill-defined disorder—Estradiol—osteoporosis	5.03e-05	0.000528	CcSEcCtD
Prednisone—Headache—Ibandronate—osteoporosis	5.03e-05	0.000527	CcSEcCtD
Prednisone—Insomnia—Conjugated Estrogens—osteoporosis	5e-05	0.000525	CcSEcCtD
Prednisone—Hypersensitivity—Ethinyl Estradiol—osteoporosis	5e-05	0.000524	CcSEcCtD
Prednisone—Vomiting—Calcitriol—osteoporosis	4.99e-05	0.000524	CcSEcCtD
Prednisone—Decreased appetite—Zoledronate—osteoporosis	4.99e-05	0.000524	CcSEcCtD
Prednisone—Agitation—Estradiol—osteoporosis	4.98e-05	0.000523	CcSEcCtD
Prednisone—Nausea—Estropipate—osteoporosis	4.97e-05	0.000522	CcSEcCtD
Prednisone—Body temperature increased—Pamidronate—osteoporosis	4.97e-05	0.000521	CcSEcCtD
Prednisone—Abdominal pain—Pamidronate—osteoporosis	4.97e-05	0.000521	CcSEcCtD
Prednisone—Paraesthesia—Conjugated Estrogens—osteoporosis	4.96e-05	0.000521	CcSEcCtD
Prednisone—HSD11B1—Metabolism—ADCY5—osteoporosis	4.96e-05	0.00171	CbGpPWpGaD
Prednisone—Angioedema—Estradiol—osteoporosis	4.95e-05	0.00052	CcSEcCtD
Prednisone—Rash—Calcitriol—osteoporosis	4.95e-05	0.00052	CcSEcCtD
Prednisone—Fatigue—Zoledronate—osteoporosis	4.95e-05	0.000519	CcSEcCtD
Prednisone—Dermatitis—Calcitriol—osteoporosis	4.95e-05	0.000519	CcSEcCtD
Prednisone—HSD11B1—Metabolism—GPX1—osteoporosis	4.94e-05	0.0017	CbGpPWpGaD
Prednisone—Headache—Calcitriol—osteoporosis	4.92e-05	0.000516	CcSEcCtD
Prednisone—Constipation—Zoledronate—osteoporosis	4.91e-05	0.000515	CcSEcCtD
Prednisone—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	4.9e-05	0.00168	CbGpPWpGaD
Prednisone—Nausea—Alendronate—osteoporosis	4.9e-05	0.000514	CcSEcCtD
Prednisone—Malaise—Estradiol—osteoporosis	4.89e-05	0.000513	CcSEcCtD
Prednisone—Hypersensitivity—Risedronate—osteoporosis	4.87e-05	0.000511	CcSEcCtD
Prednisone—Vertigo—Estradiol—osteoporosis	4.87e-05	0.000511	CcSEcCtD
Prednisone—Dyspepsia—Conjugated Estrogens—osteoporosis	4.87e-05	0.000511	CcSEcCtD
Prednisone—Asthenia—Ethinyl Estradiol—osteoporosis	4.87e-05	0.000511	CcSEcCtD
Prednisone—Syncope—Estradiol—osteoporosis	4.86e-05	0.00051	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—TLN1—osteoporosis	4.85e-05	0.00167	CbGpPWpGaD
Prednisone—Nausea—Raloxifene—osteoporosis	4.81e-05	0.000505	CcSEcCtD
Prednisone—Decreased appetite—Conjugated Estrogens—osteoporosis	4.81e-05	0.000504	CcSEcCtD
Prednisone—Pruritus—Ethinyl Estradiol—osteoporosis	4.8e-05	0.000504	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—VCL—osteoporosis	4.79e-05	0.00165	CbGpPWpGaD
Prednisone—Fatigue—Conjugated Estrogens—osteoporosis	4.77e-05	0.0005	CcSEcCtD
Prednisone—Nausea—Ibandronate—osteoporosis	4.77e-05	0.0005	CcSEcCtD
Prednisone—Loss of consciousness—Estradiol—osteoporosis	4.77e-05	0.0005	CcSEcCtD
Prednisone—Asthenia—Risedronate—osteoporosis	4.74e-05	0.000498	CcSEcCtD
Prednisone—Feeling abnormal—Zoledronate—osteoporosis	4.73e-05	0.000497	CcSEcCtD
Prednisone—Constipation—Conjugated Estrogens—osteoporosis	4.73e-05	0.000496	CcSEcCtD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	4.73e-05	0.00163	CbGpPWpGaD
Prednisone—Gastrointestinal pain—Zoledronate—osteoporosis	4.7e-05	0.000493	CcSEcCtD
Prednisone—Hypertension—Estradiol—osteoporosis	4.68e-05	0.000491	CcSEcCtD
Prednisone—Pruritus—Risedronate—osteoporosis	4.68e-05	0.000491	CcSEcCtD
Prednisone—Nausea—Calcitriol—osteoporosis	4.67e-05	0.00049	CcSEcCtD
Prednisone—Diarrhoea—Ethinyl Estradiol—osteoporosis	4.64e-05	0.000487	CcSEcCtD
Prednisone—Hypersensitivity—Pamidronate—osteoporosis	4.63e-05	0.000486	CcSEcCtD
Prednisone—Arthralgia—Estradiol—osteoporosis	4.62e-05	0.000484	CcSEcCtD
Prednisone—Myalgia—Estradiol—osteoporosis	4.62e-05	0.000484	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—SOD2—osteoporosis	4.61e-05	0.00159	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IRS2—osteoporosis	4.61e-05	0.00158	CbGpPWpGaD
Prednisone—Anxiety—Estradiol—osteoporosis	4.6e-05	0.000483	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	4.58e-05	0.000481	CcSEcCtD
Prednisone—HSD11B1—Metabolism—MTHFR—osteoporosis	4.56e-05	0.00157	CbGpPWpGaD
Prednisone—Urticaria—Zoledronate—osteoporosis	4.56e-05	0.000479	CcSEcCtD
Prednisone—Discomfort—Estradiol—osteoporosis	4.56e-05	0.000479	CcSEcCtD
Prednisone—Abdominal pain—Zoledronate—osteoporosis	4.54e-05	0.000476	CcSEcCtD
Prednisone—Body temperature increased—Zoledronate—osteoporosis	4.54e-05	0.000476	CcSEcCtD
Prednisone—Diarrhoea—Risedronate—osteoporosis	4.52e-05	0.000475	CcSEcCtD
Prednisone—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	4.52e-05	0.000474	CcSEcCtD
Prednisone—Asthenia—Pamidronate—osteoporosis	4.51e-05	0.000473	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—LEP—osteoporosis	4.51e-05	0.00155	CbGpPWpGaD
Prednisone—Dizziness—Ethinyl Estradiol—osteoporosis	4.48e-05	0.000471	CcSEcCtD
Prednisone—Pruritus—Pamidronate—osteoporosis	4.45e-05	0.000467	CcSEcCtD
Prednisone—Anaphylactic shock—Estradiol—osteoporosis	4.42e-05	0.000464	CcSEcCtD
Prednisone—Oedema—Estradiol—osteoporosis	4.42e-05	0.000464	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—GPX1—osteoporosis	4.4e-05	0.00151	CbGpPWpGaD
Prednisone—Infection—Estradiol—osteoporosis	4.4e-05	0.000461	CcSEcCtD
Prednisone—Urticaria—Conjugated Estrogens—osteoporosis	4.39e-05	0.000461	CcSEcCtD
Prednisone—Dizziness—Risedronate—osteoporosis	4.37e-05	0.000459	CcSEcCtD
Prednisone—Abdominal pain—Conjugated Estrogens—osteoporosis	4.37e-05	0.000459	CcSEcCtD
Prednisone—Body temperature increased—Conjugated Estrogens—osteoporosis	4.37e-05	0.000459	CcSEcCtD
Prednisone—Shock—Estradiol—osteoporosis	4.35e-05	0.000457	CcSEcCtD
Prednisone—Nervous system disorder—Estradiol—osteoporosis	4.34e-05	0.000455	CcSEcCtD
Prednisone—Tachycardia—Estradiol—osteoporosis	4.32e-05	0.000453	CcSEcCtD
Prednisone—Vomiting—Ethinyl Estradiol—osteoporosis	4.31e-05	0.000453	CcSEcCtD
Prednisone—Diarrhoea—Pamidronate—osteoporosis	4.3e-05	0.000451	CcSEcCtD
Prednisone—Skin disorder—Estradiol—osteoporosis	4.3e-05	0.000451	CcSEcCtD
Prednisone—Hyperhidrosis—Estradiol—osteoporosis	4.28e-05	0.000449	CcSEcCtD
Prednisone—Rash—Ethinyl Estradiol—osteoporosis	4.28e-05	0.000449	CcSEcCtD
Prednisone—Dermatitis—Ethinyl Estradiol—osteoporosis	4.27e-05	0.000448	CcSEcCtD
Prednisone—Headache—Ethinyl Estradiol—osteoporosis	4.25e-05	0.000446	CcSEcCtD
Prednisone—Hypersensitivity—Zoledronate—osteoporosis	4.23e-05	0.000444	CcSEcCtD
Prednisone—Vomiting—Risedronate—osteoporosis	4.2e-05	0.000441	CcSEcCtD
Prednisone—Rash—Risedronate—osteoporosis	4.17e-05	0.000438	CcSEcCtD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—LEP—osteoporosis	4.17e-05	0.00143	CbGpPWpGaD
Prednisone—Dermatitis—Risedronate—osteoporosis	4.17e-05	0.000437	CcSEcCtD
Prednisone—Dizziness—Pamidronate—osteoporosis	4.16e-05	0.000436	CcSEcCtD
Prednisone—Headache—Risedronate—osteoporosis	4.14e-05	0.000435	CcSEcCtD
Prednisone—Asthenia—Zoledronate—osteoporosis	4.12e-05	0.000432	CcSEcCtD
Prednisone—Hypersensitivity—Conjugated Estrogens—osteoporosis	4.07e-05	0.000427	CcSEcCtD
Prednisone—Pruritus—Zoledronate—osteoporosis	4.06e-05	0.000426	CcSEcCtD
Prednisone—ALB—Selenium Micronutrient Network—MTHFR—osteoporosis	4.06e-05	0.0014	CbGpPWpGaD
Prednisone—Musculoskeletal discomfort—Estradiol—osteoporosis	4.03e-05	0.000423	CcSEcCtD
Prednisone—Nausea—Ethinyl Estradiol—osteoporosis	4.03e-05	0.000423	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—IRS1—osteoporosis	4.02e-05	0.00138	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	4.02e-05	0.00138	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	4.02e-05	0.00138	CbGpPWpGaD
Prednisone—Insomnia—Estradiol—osteoporosis	4e-05	0.00042	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—RAP1A—osteoporosis	4e-05	0.00138	CbGpPWpGaD
Prednisone—Vomiting—Pamidronate—osteoporosis	4e-05	0.000419	CcSEcCtD
Prednisone—ALB—Hemostasis—CAP1—osteoporosis	3.99e-05	0.00137	CbGpPWpGaD
Prednisone—Paraesthesia—Estradiol—osteoporosis	3.97e-05	0.000417	CcSEcCtD
Prednisone—Asthenia—Conjugated Estrogens—osteoporosis	3.97e-05	0.000416	CcSEcCtD
Prednisone—Rash—Pamidronate—osteoporosis	3.96e-05	0.000416	CcSEcCtD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	3.96e-05	0.00136	CbGpPWpGaD
Prednisone—Dermatitis—Pamidronate—osteoporosis	3.96e-05	0.000416	CcSEcCtD
Prednisone—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	3.96e-05	0.00136	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—RAP1A—osteoporosis	3.94e-05	0.00135	CbGpPWpGaD
Prednisone—Headache—Pamidronate—osteoporosis	3.94e-05	0.000413	CcSEcCtD
Prednisone—Diarrhoea—Zoledronate—osteoporosis	3.93e-05	0.000412	CcSEcCtD
Prednisone—Nausea—Risedronate—osteoporosis	3.93e-05	0.000412	CcSEcCtD
Prednisone—Pruritus—Conjugated Estrogens—osteoporosis	3.91e-05	0.00041	CcSEcCtD
Prednisone—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	3.91e-05	0.00134	CbGpPWpGaD
Prednisone—Dyspepsia—Estradiol—osteoporosis	3.9e-05	0.000409	CcSEcCtD
Prednisone—Decreased appetite—Estradiol—osteoporosis	3.85e-05	0.000404	CcSEcCtD
Prednisone—Fatigue—Estradiol—osteoporosis	3.81e-05	0.0004	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.81e-05	0.00131	CbGpPWpGaD
Prednisone—Dizziness—Zoledronate—osteoporosis	3.8e-05	0.000398	CcSEcCtD
Prednisone—Constipation—Estradiol—osteoporosis	3.78e-05	0.000397	CcSEcCtD
Prednisone—Diarrhoea—Conjugated Estrogens—osteoporosis	3.78e-05	0.000397	CcSEcCtD
Prednisone—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	3.75e-05	0.00129	CbGpPWpGaD
Prednisone—Nausea—Pamidronate—osteoporosis	3.73e-05	0.000392	CcSEcCtD
Prednisone—NR3C1—Adipogenesis—IGF1—osteoporosis	3.73e-05	0.00128	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL1B—osteoporosis	3.73e-05	0.00128	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	3.67e-05	0.00126	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	3.67e-05	0.00126	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—FDPS—osteoporosis	3.66e-05	0.00126	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PKM—osteoporosis	3.66e-05	0.00126	CbGpPWpGaD
Prednisone—Dizziness—Conjugated Estrogens—osteoporosis	3.66e-05	0.000384	CcSEcCtD
Prednisone—Vomiting—Zoledronate—osteoporosis	3.65e-05	0.000383	CcSEcCtD
Prednisone—HSD11B1—Metabolism—POMC—osteoporosis	3.65e-05	0.00125	CbGpPWpGaD
Prednisone—Feeling abnormal—Estradiol—osteoporosis	3.65e-05	0.000383	CcSEcCtD
Prednisone—ALB—Platelet activation, signaling and aggregation—FGA—osteoporosis	3.63e-05	0.00125	CbGpPWpGaD
Prednisone—Rash—Zoledronate—osteoporosis	3.62e-05	0.00038	CcSEcCtD
Prednisone—Gastrointestinal pain—Estradiol—osteoporosis	3.62e-05	0.00038	CcSEcCtD
Prednisone—Dermatitis—Zoledronate—osteoporosis	3.62e-05	0.00038	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—FDPS—osteoporosis	3.61e-05	0.00124	CbGpPWpGaD
Prednisone—Headache—Zoledronate—osteoporosis	3.6e-05	0.000377	CcSEcCtD
Prednisone—Vomiting—Conjugated Estrogens—osteoporosis	3.52e-05	0.000369	CcSEcCtD
Prednisone—Urticaria—Estradiol—osteoporosis	3.52e-05	0.000369	CcSEcCtD
Prednisone—Abdominal pain—Estradiol—osteoporosis	3.5e-05	0.000367	CcSEcCtD
Prednisone—Body temperature increased—Estradiol—osteoporosis	3.5e-05	0.000367	CcSEcCtD
Prednisone—Rash—Conjugated Estrogens—osteoporosis	3.49e-05	0.000366	CcSEcCtD
Prednisone—Dermatitis—Conjugated Estrogens—osteoporosis	3.48e-05	0.000365	CcSEcCtD
Prednisone—SLCO1A2—Metabolism—PGLS—osteoporosis	3.47e-05	0.00119	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GPD2—osteoporosis	3.47e-05	0.00119	CbGpPWpGaD
Prednisone—Headache—Conjugated Estrogens—osteoporosis	3.46e-05	0.000363	CcSEcCtD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GPD2—osteoporosis	3.42e-05	0.00118	CbGpPWpGaD
Prednisone—Nausea—Zoledronate—osteoporosis	3.41e-05	0.000358	CcSEcCtD
Prednisone—ALB—Platelet degranulation—IGF1—osteoporosis	3.37e-05	0.00116	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—FGB—osteoporosis	3.3e-05	0.00114	CbGpPWpGaD
Prednisone—Nausea—Conjugated Estrogens—osteoporosis	3.28e-05	0.000345	CcSEcCtD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	3.27e-05	0.00112	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	3.27e-05	0.00112	CbGpPWpGaD
Prednisone—Hypersensitivity—Estradiol—osteoporosis	3.26e-05	0.000342	CcSEcCtD
Prednisone—NR3C1—Gene Expression—U2AF1—osteoporosis	3.26e-05	0.00112	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	3.25e-05	0.00112	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	3.21e-05	0.0011	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—osteoporosis	3.21e-05	0.0011	CbGpPWpGaD
Prednisone—CYP2C19—Phase 1 - Functionalization of compounds—POMC—osteoporosis	3.21e-05	0.0011	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	3.2e-05	0.0011	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PNP—osteoporosis	3.18e-05	0.00109	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ATIC—osteoporosis	3.18e-05	0.00109	CbGpPWpGaD
Prednisone—Asthenia—Estradiol—osteoporosis	3.17e-05	0.000333	CcSEcCtD
Prednisone—ALB—Hemostasis—MGLL—osteoporosis	3.17e-05	0.00109	CbGpPWpGaD
Prednisone—Pruritus—Estradiol—osteoporosis	3.13e-05	0.000329	CcSEcCtD
Prednisone—ALB—Folate Metabolism—IL1B—osteoporosis	3.03e-05	0.00104	CbGpPWpGaD
Prednisone—Diarrhoea—Estradiol—osteoporosis	3.03e-05	0.000318	CcSEcCtD
Prednisone—ALB—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.96e-05	0.00102	CbGpPWpGaD
Prednisone—Dizziness—Estradiol—osteoporosis	2.93e-05	0.000307	CcSEcCtD
Prednisone—ALB—Hemostasis—PLEK—osteoporosis	2.9e-05	0.000998	CbGpPWpGaD
Prednisone—ALB—Hemostasis—ANXA2—osteoporosis	2.9e-05	0.000998	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.89e-05	0.000993	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—CYP19A1—osteoporosis	2.84e-05	0.000975	CbGpPWpGaD
Prednisone—Vomiting—Estradiol—osteoporosis	2.81e-05	0.000295	CcSEcCtD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—osteoporosis	2.8e-05	0.000964	CbGpPWpGaD
Prednisone—CYP2C19—Metapathway biotransformation—CYP19A1—osteoporosis	2.8e-05	0.000962	CbGpPWpGaD
Prednisone—Rash—Estradiol—osteoporosis	2.79e-05	0.000293	CcSEcCtD
Prednisone—Dermatitis—Estradiol—osteoporosis	2.79e-05	0.000292	CcSEcCtD
Prednisone—Headache—Estradiol—osteoporosis	2.77e-05	0.000291	CcSEcCtD
Prednisone—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	2.76e-05	0.00095	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—osteoporosis	2.7e-05	0.00093	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—OXCT1—osteoporosis	2.7e-05	0.000929	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CA2—osteoporosis	2.7e-05	0.000929	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—OXCT1—osteoporosis	2.66e-05	0.000915	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—MGLL—osteoporosis	2.63e-05	0.000906	CbGpPWpGaD
Prednisone—Nausea—Estradiol—osteoporosis	2.63e-05	0.000276	CcSEcCtD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—osteoporosis	2.63e-05	0.000903	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—MGLL—osteoporosis	2.59e-05	0.000892	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	2.59e-05	0.000891	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.51e-05	0.000864	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TLN1—osteoporosis	2.5e-05	0.00086	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	2.48e-05	0.000854	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	2.48e-05	0.000854	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VCL—osteoporosis	2.47e-05	0.000849	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	2.43e-05	0.000837	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—RPL24—osteoporosis	2.42e-05	0.000832	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL1B—osteoporosis	2.41e-05	0.000828	CbGpPWpGaD
Prednisone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	2.38e-05	0.000818	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.31e-05	0.000794	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—IL1B—osteoporosis	2.3e-05	0.000791	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—IDH2—osteoporosis	2.24e-05	0.00077	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TGFB1—osteoporosis	2.23e-05	0.000768	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ANXA2—osteoporosis	2.2e-05	0.000757	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—osteoporosis	2.2e-05	0.000757	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—IL6—osteoporosis	2.18e-05	0.00075	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP27A1—osteoporosis	2.1e-05	0.000724	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—osteoporosis	2.09e-05	0.000717	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP27A1—osteoporosis	2.07e-05	0.000713	CbGpPWpGaD
Prednisone—ALB—Hemostasis—RAP1A—osteoporosis	2.06e-05	0.000709	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	2.06e-05	0.000707	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ACP5—osteoporosis	2.05e-05	0.000704	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	2.02e-05	0.000695	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—TGFB1—osteoporosis	2.02e-05	0.000695	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.96e-05	0.000675	CbGpPWpGaD
Prednisone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.93e-05	0.000664	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.93e-05	0.000663	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—osteoporosis	1.92e-05	0.000662	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TPI1—osteoporosis	1.9e-05	0.000655	CbGpPWpGaD
Prednisone—ALB—Hemostasis—FGA—osteoporosis	1.87e-05	0.000643	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.8e-05	0.00062	CbGpPWpGaD
Prednisone—ALB—Metabolism—PKM—osteoporosis	1.79e-05	0.000616	CbGpPWpGaD
Prednisone—ALB—Metabolism—FDPS—osteoporosis	1.79e-05	0.000616	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—P4HB—osteoporosis	1.79e-05	0.000616	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TGFB1—osteoporosis	1.79e-05	0.000615	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—IL6—osteoporosis	1.78e-05	0.00061	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—P4HB—osteoporosis	1.76e-05	0.000606	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GAPDH—osteoporosis	1.76e-05	0.000604	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—osteoporosis	1.75e-05	0.000601	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—RAP1A—osteoporosis	1.71e-05	0.000588	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	1.71e-05	0.000586	CbGpPWpGaD
Prednisone—CYP2C19—Biological oxidations—POMC—osteoporosis	1.7e-05	0.000586	CbGpPWpGaD
Prednisone—ALB—Hemostasis—FGB—osteoporosis	1.7e-05	0.000585	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—osteoporosis	1.7e-05	0.000585	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPD2—osteoporosis	1.7e-05	0.000584	CbGpPWpGaD
Prednisone—ALB—Metabolism—PGLS—osteoporosis	1.7e-05	0.000584	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—IL6—osteoporosis	1.68e-05	0.000579	CbGpPWpGaD
Prednisone—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	1.68e-05	0.000578	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—osteoporosis	1.67e-05	0.000574	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PKM—osteoporosis	1.61e-05	0.000553	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—FDPS—osteoporosis	1.61e-05	0.000553	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	1.57e-05	0.000541	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PKM—osteoporosis	1.57e-05	0.00054	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—FDPS—osteoporosis	1.57e-05	0.00054	CbGpPWpGaD
Prednisone—ALB—Metabolism—ATIC—osteoporosis	1.55e-05	0.000534	CbGpPWpGaD
Prednisone—ALB—Metabolism—PNP—osteoporosis	1.55e-05	0.000534	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PGLS—osteoporosis	1.52e-05	0.000524	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPD2—osteoporosis	1.52e-05	0.000524	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—IGF1—osteoporosis	1.49e-05	0.000514	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—POMC—osteoporosis	1.49e-05	0.000513	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PGLS—osteoporosis	1.49e-05	0.000511	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPD2—osteoporosis	1.49e-05	0.000511	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.47e-05	0.000506	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	1.45e-05	0.0005	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—IL6—osteoporosis	1.41e-05	0.000485	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSMA2—osteoporosis	1.4e-05	0.00048	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PSMA5—osteoporosis	1.4e-05	0.00048	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ATIC—osteoporosis	1.39e-05	0.000479	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PNP—osteoporosis	1.39e-05	0.000479	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ENO1—osteoporosis	1.38e-05	0.000476	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSMA2—osteoporosis	1.36e-05	0.000469	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PSMA5—osteoporosis	1.36e-05	0.000469	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PNP—osteoporosis	1.36e-05	0.000468	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ATIC—osteoporosis	1.36e-05	0.000468	CbGpPWpGaD
Prednisone—ALB—Metabolism—CA2—osteoporosis	1.32e-05	0.000454	CbGpPWpGaD
Prednisone—ALB—Metabolism—OXCT1—osteoporosis	1.32e-05	0.000454	CbGpPWpGaD
Prednisone—ALB—Metabolism—MGLL—osteoporosis	1.29e-05	0.000442	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR2—osteoporosis	1.25e-05	0.000429	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.21e-05	0.000417	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—OXCT1—osteoporosis	1.18e-05	0.000408	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CA2—osteoporosis	1.18e-05	0.000408	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CA2—osteoporosis	1.16e-05	0.000398	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—OXCT1—osteoporosis	1.16e-05	0.000398	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MGLL—osteoporosis	1.15e-05	0.000397	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MGLL—osteoporosis	1.13e-05	0.000388	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CYP19A1—osteoporosis	1.11e-05	0.00038	CbGpPWpGaD
Prednisone—ALB—Metabolism—IDH2—osteoporosis	1.09e-05	0.000376	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—osteoporosis	1.09e-05	0.000375	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP27A1—osteoporosis	1.03e-05	0.000354	CbGpPWpGaD
Prednisone—CYP3A4—Biological oxidations—POMC—osteoporosis	1.02e-05	0.000352	CbGpPWpGaD
Prednisone—ALB—Metabolism—ACP5—osteoporosis	1e-05	0.000344	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—VDR—osteoporosis	9.9e-06	0.000341	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	9.88e-06	0.00034	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—IDH2—osteoporosis	9.82e-06	0.000338	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—FDPS—osteoporosis	9.67e-06	0.000332	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PKM—osteoporosis	9.67e-06	0.000332	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—IDH2—osteoporosis	9.58e-06	0.00033	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—ADCY5—osteoporosis	9.42e-06	0.000324	CbGpPWpGaD
Prednisone—ALB—Metabolism—TPI1—osteoporosis	9.3e-06	0.00032	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP27A1—osteoporosis	9.23e-06	0.000318	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PGLS—osteoporosis	9.16e-06	0.000315	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPD2—osteoporosis	9.16e-06	0.000315	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ADCY5—osteoporosis	9.03e-06	0.000311	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP27A1—osteoporosis	9.01e-06	0.00031	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GPX1—osteoporosis	9e-06	0.00031	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ACP5—osteoporosis	8.98e-06	0.000309	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB1—osteoporosis	8.96e-06	0.000308	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—osteoporosis	8.87e-06	0.000305	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	8.84e-06	0.000304	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	8.82e-06	0.000303	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ACP5—osteoporosis	8.77e-06	0.000301	CbGpPWpGaD
Prednisone—ALB—Metabolism—P4HB—osteoporosis	8.74e-06	0.000301	CbGpPWpGaD
Prednisone—ALB—Metabolism—GAPDH—osteoporosis	8.58e-06	0.000295	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PNP—osteoporosis	8.38e-06	0.000288	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ATIC—osteoporosis	8.38e-06	0.000288	CbGpPWpGaD
Prednisone—ALB—Metabolism—RAP1A—osteoporosis	8.36e-06	0.000288	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TPI1—osteoporosis	8.35e-06	0.000287	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—MTHFR—osteoporosis	8.31e-06	0.000286	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	8.26e-06	0.000284	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	8.24e-06	0.000283	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	8.18e-06	0.000281	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TPI1—osteoporosis	8.15e-06	0.00028	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—P4HB—osteoporosis	7.85e-06	0.00027	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GAPDH—osteoporosis	7.7e-06	0.000265	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IGF1—osteoporosis	7.7e-06	0.000265	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—P4HB—osteoporosis	7.66e-06	0.000264	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—ESR1—osteoporosis	7.57e-06	0.00026	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GAPDH—osteoporosis	7.52e-06	0.000259	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—RAP1A—osteoporosis	7.5e-06	0.000258	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—RAP1A—osteoporosis	7.32e-06	0.000252	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—POMC—osteoporosis	7.29e-06	0.000251	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CA2—osteoporosis	7.13e-06	0.000245	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—OXCT1—osteoporosis	7.13e-06	0.000245	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MGLL—osteoporosis	6.94e-06	0.000239	CbGpPWpGaD
Prednisone—ALB—Metabolism—ENO1—osteoporosis	6.76e-06	0.000232	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSMA5—osteoporosis	6.66e-06	0.000229	CbGpPWpGaD
Prednisone—ALB—Metabolism—PSMA2—osteoporosis	6.66e-06	0.000229	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—POMC—osteoporosis	6.64e-06	0.000229	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—POMC—osteoporosis	6.54e-06	0.000225	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ENO1—osteoporosis	6.07e-06	0.000209	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSMA2—osteoporosis	5.98e-06	0.000206	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PSMA5—osteoporosis	5.98e-06	0.000206	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ENO1—osteoporosis	5.92e-06	0.000204	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—IDH2—osteoporosis	5.9e-06	0.000203	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSMA5—osteoporosis	5.83e-06	0.000201	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PSMA2—osteoporosis	5.83e-06	0.000201	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP27A1—osteoporosis	5.55e-06	0.000191	CbGpPWpGaD
Prednisone—ALB—Metabolism—CYP19A1—osteoporosis	5.4e-06	0.000186	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ACP5—osteoporosis	5.4e-06	0.000186	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TPI1—osteoporosis	5.02e-06	0.000173	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CYP19A1—osteoporosis	4.85e-06	0.000167	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CYP19A1—osteoporosis	4.73e-06	0.000163	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—P4HB—osteoporosis	4.72e-06	0.000162	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GAPDH—osteoporosis	4.63e-06	0.000159	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—osteoporosis	4.62e-06	0.000159	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—RAP1A—osteoporosis	4.51e-06	0.000155	CbGpPWpGaD
Prednisone—ALB—Metabolism—ADCY5—osteoporosis	4.41e-06	0.000152	CbGpPWpGaD
Prednisone—ALB—Metabolism—GPX1—osteoporosis	4.4e-06	0.000151	CbGpPWpGaD
Prednisone—ALB—Metabolism—MTHFR—osteoporosis	4.06e-06	0.00014	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ADCY5—osteoporosis	3.96e-06	0.000136	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GPX1—osteoporosis	3.95e-06	0.000136	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—osteoporosis	3.94e-06	0.000135	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ADCY5—osteoporosis	3.87e-06	0.000133	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GPX1—osteoporosis	3.85e-06	0.000133	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ENO1—osteoporosis	3.65e-06	0.000125	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—MTHFR—osteoporosis	3.64e-06	0.000125	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSMA5—osteoporosis	3.59e-06	0.000124	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PSMA2—osteoporosis	3.59e-06	0.000124	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—MTHFR—osteoporosis	3.56e-06	0.000122	CbGpPWpGaD
Prednisone—ALB—Metabolism—POMC—osteoporosis	3.25e-06	0.000112	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.92e-06	0.0001	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—POMC—osteoporosis	2.91e-06	0.0001	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—POMC—osteoporosis	2.84e-06	9.78e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ADCY5—osteoporosis	2.38e-06	8.19e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GPX1—osteoporosis	2.37e-06	8.17e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—MTHFR—osteoporosis	2.19e-06	7.54e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—POMC—osteoporosis	1.75e-06	6.03e-05	CbGpPWpGaD
